anaRIC biologics is a joint venture between Anacura and the Research Institute for Chromatography (RIC), two family-owned centers with excellent records in the field of analytics based in Belgium.
Working closely with our pharma customers for many years we have experienced first-hand how profound product understanding is a critical attribute for success. However, obtaining this analytical insight is a continuous process and its scope evolves during each development process, covering both non-GMP and GMP activities.
Anacura and the RIC bring to the table respectively 15 years of GMP and 30 years of R&D experience.
United by our passion for analytics we can support you through all phases of your product’s lifecycle: from early lead selection and product characterization, across method development and validation, over comparability, clinical and commercial release and stability testing.
As a state-of-the art, flexible extension of your in-house capabilities, our continuous involvement creates an effective learning platform and ensures you have the right analytical tools and data available at the right time.